BIOMAT Database Logo BIOMAT Database Logo

Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. 1988

A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Division of Haematology, Ospedale S. Martino, Genoa, Italy.

Twenty-five patients with acute non-lymphoblastic leukemia (ANLL) in first complete remission underwent autologous bone marrow transplantation (ABMT) between March 1984 and March 1988. The high-dose therapy employed included cyclophosphamide followed by total body irradiation (10 Gy), administered as a single dose. The median time from complete remission to ABMT was 5 months (range 2-9 months). Thirteen (52%) patients remain in complete remission 10-51 months (median 25 months) after ABMT and 14-60 months (median 32 months) after achieving complete remission. Causes of death were recurrent leukemia (five patients), parenchymal toxicities (acute respiratory distress syndrome, veno-occlusive disease) (three patients), cerebral haemorrhage (one patient), cerebral aspergillosis (one patient) and viral hepatitis (one patient). Six patients relapsed at a median of 5 months after ABMT (range 4-10 months). In conclusion, this study has resulted in survival data comparable to those of other institutions and the best reported outcomes of conventional chemotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous

Related Publications

A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.
January 1991, Leukemia & lymphoma,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Autologous bone marrow transplantation (ABMT) using unpurged marrow as intensification for first complete remission in acute leukaemia (AL).
January 1989, Folia haematologica (Leipzig, Germany : 1928),
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Transplantation of unpurged autologous bone-marrow in acute myeloid leukaemia in first remission.
November 1984, Lancet (London, England),
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission.
March 1988, Bone marrow transplantation,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
July 1991, Bone marrow transplantation,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
January 1990, Bone marrow transplantation,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Autologous bone marrow transplantation for second or greater complete remission of acute myeloid leukaemia and acute lymphoblastic leukaemia.
July 1995, Leukemia & lymphoma,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
January 1989, Bone marrow transplantation,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Allogeneic and autologous bone marrow transplantation for acute non-lymphoblastic leukaemia.
August 1994, Journal of paediatrics and child health,
A M Carella, and E Gaozza, and G Santini, and M Martinengo, and E Pungolino, and G Piatti, and A Congiu, and S Nati, and P Carlier, and D Giordano
Autologous bone marrow transplantation for acute leukaemia in remission.
October 1986, British journal of haematology,
Copied contents to your clipboard!